Yohimbine hydrochloride

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C21H26N2O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NB2E1YP49F, chemically known as 20.alpha.-yohimban-16.beta.-carboxylic acid, 17.alpha.-hydroxy-, methyl ester, monohydrochloride but more generally known as yohimbine hydrochloride, which bears US NIH Compound Identifier 2866. European Medicines Agency schedules Yohimbine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15745MIG. Most nations, for tariff and trade purposes, schedule yohimbine hydrochloride under HS 29399990 and SITC 54149. As of Q4 2014, YOHIMBINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Yohimbine hydrochloride bears US NLM identifiers UMLS ID C0521933 and NCI Concept Code C75062. SMILES: COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4C(C5CCCCC5[NH]4)CCN3C2)O.CL.